Literature DB >> 15301895

Apoptotic/mytogenic pathways during human heart development.

Paolo Fiorina1, Domenico Corradi, Silvana Pinelli, Roberta Maestri, Costanza Lagrasta, Mauro Buscaglia, Alberto Davalli, Franco Folli, Ettore Astorri.   

Abstract

OBJECTIVE: The aim of our study was to assess myocytes apoptosis/mitosis and associated intracellular signalling pathways during heart development. SETTING AND PATIENTS: Eight human fetal hearts (at different gestation ages) and seven human adult hearts were chosen as controls (five normal and two pathological) and studied from both a histological and a molecular point of view.
RESULTS: Our results are as follows: (i) all Shc isoforms are expressed and activated in the human fetal heart; (ii) a progressive fading of Shc and ERK expression are evident during gestation; (iii) JNK is present but it is not activated in the human fetal heart; (iv) CD95 is present in the first week of gestation and fades progressively; (v) apoptotic/proliferative processes are present in the early gestation phase and fades progressively; (vi) in the human heart, Shc isoform with medium weight is 55 kD and not 52 kD and it is upregulated in adult myocardial ischaemia.
CONCLUSIONS: Myocyte underwent apoptosis/mitosis during gestation. Shc isoforms, together with ERK maintain the homeostasis of the heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301895     DOI: 10.1016/j.ijcard.2003.08.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Silencing of FABP3 promotes apoptosis and induces mitochondrion impairment in embryonic carcinoma cells.

Authors:  Ya-Hui Shen; Gui-Xian Song; Yao-Qiu Liu; Wei Sun; Li-Juan Zhou; Hai-Lang Liu; Rong Yang; Yan-Hui Sheng; Ling-Mei Qian; Xiang-Qing Kong
Journal:  J Bioenerg Biomembr       Date:  2012-04-20       Impact factor: 2.945

2.  α-Lipoic acid ameliorates mitochondrial impairment and reverses apoptosis in FABP3-overexpressing embryonic cancer cells.

Authors:  Lijuan Zhou; Jin Jin; Guixian Song; Hailang Liu; Ming Liu; Chunmei Shi; Lingmei Qian
Journal:  J Bioenerg Biomembr       Date:  2013-03-28       Impact factor: 2.945

3.  Regional expression of the hypoxia-inducible factor (HIF) system and association with cardiomyocyte cell cycle re-entry after myocardial infarction in rats.

Authors:  Chen-Guang Bai; Xiao-Hong Liu; Wei-Qiang Liu; Da-Lie Ma
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

4.  Effect of LYRM1 knockdown on proliferation, apoptosis, differentiation and mitochondrial function in the P19 cell model of cardiac differentiation in vitro.

Authors:  Yu-Mei Chen; Xing Li; Gui-Xian Song; Ming Liu; Yi Fan; Li-Jie Wu; Hua Li; Qi-Jun Zhang; Yao-Qiu Liu; Ling-Mei Qian
Journal:  J Bioenerg Biomembr       Date:  2016-01-13       Impact factor: 2.945

5.  LYRM1, a gene that promotes proliferation and inhibits apoptosis during heart development.

Authors:  Chun Zhu; Yao-Qiu Liu; Fu-Kun Chen; De-Liang Hu; Zhang-Bin Yu; Ling-Mei Qian
Journal:  Molecules       Date:  2010-10-11       Impact factor: 4.411

6.  Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes.

Authors:  Bayardo I Garay; Sophie Givens; Phablo Abreu; Man Liu; Doğacan Yücel; June Baik; Noah Stanis; Taylor M Rothermel; Alessandro Magli; Juan E Abrahante; Natalya A Goloviznina; Hossam A N Soliman; Neha R Dhoke; Michael Kyba; Patrick W Alford; Samuel C Dudley; Jop H van Berlo; Brenda Ogle; Rita R C Perlingeiro
Journal:  Stem Cell Reports       Date:  2022-08-04       Impact factor: 7.294

7.  Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells.

Authors:  Xuehua Liu; Liming Yang; Huiyan Wang; Guofeng Xu; Shasha Zhu; Mengmeng Li; Xiaoshan Hu; Jingai Zhu; Chun Zhu; Jing Xu; Shuping Han; Zhangbin Yu
Journal:  Mol Med Rep       Date:  2014-12-03       Impact factor: 2.952

8.  miR-30c regulates proliferation, apoptosis and differentiation via the Shh signaling pathway in P19 cells.

Authors:  Xuehua Liu; Mengmeng Li; Yuzhu Peng; Xiaoshan Hu; Jing Xu; Shasha Zhu; Zhangbin Yu; Shuping Han
Journal:  Exp Mol Med       Date:  2016-07-29       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.